Generated Narrative: StructureDefinition MyHealthEuAllergyIntolerance Name Flags Card. Type Description & Constraints MyHealthEuAllergyIntolerance 0..* EHDSAllergyIntolerance Allergy intolerance model Elements defined in Ancestors:header, <a href="http://www.xt-ehr.eu/fhir/models/0.3.0/StructureDefinition-EHDSAllergyIntolerance.html" title="Code for an allergy or intolerance statement (either a positive or a negated/excluded statement). This may be a code for a substance or pharmaceutical product that is considered to be responsible for the adverse reaction risk (e.g., "Latex"), an allergy or intolerance condition (e.g., "Latex allergy"), or a negated/excluded code for a specific substance or class (e.g., "No latex allergy")#xA; It must be clinically safe to only process the 'code' and ignore the 'reaction.substance'. ">agentOrAllergen, note, criticality, certainty, onsetDate, endDate, reaction #xD; header #xD; status O 1..1 CodeableConcept Current status of the allergy or intolerance, for example, whether it is active, in remission, resolved, etc. Obligations Actor MAY:able-to-populate Imaging Handler #xD; agentOrAllergen O 1..1 CodeableConcept Code that identifies the allergy or intolerance Obligations Actor SHOULD:handle Imaging Handler #xD; note O 0..1 string Additional information about the allergy or intolerance Obligations Actor SHOULD:handle Imaging Handler #xD; criticality O 0..1 CodeableConcept Estimate of the potential clinical harm, or seriousness, of a reaction to an identified substance. Obligations Actor MAY:able-to-populate Imaging Handler #xD; certainty O 0..1 CodeableConcept Assertion about the certainty associated with a propensity, or potential risk, of a reaction to the identified substance. Diagnostic and /or clinical evidence of condition Obligations Actor MAY:able-to-populate Imaging Handler #xD; onsetDate O 0..1 dateTime When allergy or intolerance was identified Obligations Actor MAY:able-to-populate Imaging Handler #xD; endDate O 0..1 dateTime Date of resolution of the allergy (e.g. when the clinician deemed there is no longer any need to track the underlying condition) Obligations Actor MAY:able-to-populate Imaging Handler #xD; reaction #xD; manifestation O 0..* CodeableConcept Description of the clinical manifestation of the allergic reaction. Example: anaphylactic shock, angioedema. (the clinical manifestation also gives information about the severity of the observed reaction). Obligations Actor MAY:able-to-populate Imaging Handler #xD; severity O 0..1 CodeableConcept Severity of the clinical manifestation of the allergic reaction. Obligations Actor MAY:able-to-populate Imaging Handler #xD; Documentation for this format
MyHealth@EU refined model for the Allergy and Intolerance in the context of imaging
Business identifier for the object, unique within its system. Supporting disambiguation between different contexts (systems/countries).
The author of the allergy/intolerance information.
Date and optionally time of authoring/issuing
Current status of the allergy or intolerance, for example, whether it is active, in remission, resolved, etc.
Source of information (e.g. patient, patient's proxy). Used in case the patient has authored the information or the author has submitted patient-stated information.
Language in which the resource is written. Language is expressed by the IETF language tag.
Code that identifies the allergy or intolerance
Code for an allergy or intolerance statement (either a positive or a negated/excluded statement). This may be a code for a substance or pharmaceutical product that is considered to be responsible for the adverse reaction risk (e.g., "Latex"), an allergy or intolerance condition (e.g., "Latex allergy"), or a negated/excluded code for a specific substance or class (e.g., "No latex allergy") It must be clinically safe to only process the 'code' and ignore the 'reaction.substance'.
Additional information about the allergy or intolerance
Estimate of the potential clinical harm, or seriousness, of a reaction to an identified substance.
Assertion about the certainty associated with a propensity, or potential risk, of a reaction to the identified substance. Diagnostic and /or clinical evidence of condition
When allergy or intolerance was identified
Date of resolution of the allergy (e.g. when the clinician deemed there is no longer any need to track the underlying condition)
Adverse reaction events linked to exposure to substance.
ISO IPS (explicit), implicitly in eHN PS Guideline, MH@EU
Specific substance or pharmaceutical product considered to be responsible for event
Identification of the specific substance (or pharmaceutical product) considered to be responsible for the Adverse Reaction event. Note: the substance for a specific reaction may be different from the substance identified as the cause of the risk, but it must be consistent with it. It must be clinically safe to only process the 'code' and ignore the 'reaction.substance'.
Description of the clinical manifestation of the allergic reaction. Example: anaphylactic shock, angioedema. (the clinical manifestation also gives information about the severity of the observed reaction).
The element is present in eHN PS GL, MyHealth@EU specifications and ISO IPS. Element name and description is taken from eHN PS GL. Cardinality in MyHealth@EU for this element, used here, is one manifestation per severity and onset, while the cardinality in FHIR IPS IG allows multiple manifestations per severity and onset.
Severity of the clinical manifestation of the allergic reaction.
The element is present in eHN PS GL, MyHealth@EU specifications and ISO IPS. Element name and description is taken from eHN PS GL.
Date and time of the onset of the reaction
The element is present in eHN PS GL. Element name and description is taken from eHN PS GL.